Last updated: March 10, 2026
ACC is a rare and aggressive cancer of the adrenal cortex. ~1-2 cases per million per year. Often diagnosed at advanced stages. Can be functional (hormone-producing) or non-functional.
Active research areas in 2026:Standard of care: Resectable: surgery + adjuvant mitotane. Unresectable/metastatic: mitotane + etoposide/doxorubicin/cisplatin (EDP-M). Limited second-line options.
After surgery for resectable disease:
For newly diagnosed advanced disease:
After progression on mitotane-based therapy:
Immunotherapy trials for ACC:
View all 18 adrenocortical carcinoma trials on ClinicalTrials.gov →
Trial listings from ClinicalTrials.gov. Page summaries generated by AI and may contain errors. Always verify with your healthcare provider.
Find ACC Trials Matched to Your Situation
Use ClinTrialFinder's AI-powered matching to find trials based on your specific stage and treatment history.
Find Matching Trials